# Is Dayvigo（lemborexant) a safe sleep pill? **URL:** \ **Category:** Supplements\ **Tags:** longevity, anti-aging, sleep\ **Created:** [September 21, 2025, 10:29pm UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548 "2025-09-21T22:29:39Z")\ **Posts on this page:** 7\ **Page:** 4
**Author:** ![man\_li](https://www.rapamycin.news/user_avatar/www.rapamycin.news/man_li/32/16938_2.png) [@man\_li](https://www.rapamycin.news/u/man_li)\ **Post date:** [November 1, 2026, 10:42am UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548/65 "2026-11-01T10:42:49Z")
The “hangover effect” of traditional sleep medications is precisely why many people hesitate to use them, even when struggling with severe sleep issues. Naturally, when learning about **lemborexant** , many are faced with a major question: with a half-life as long as 17–19 hours—much longer than zolpidem (2–3 hours) or zopiclone (approx. 6 hours)—will it leave users feeling groggy all through the next day? Clinical studies offer a strikingly different answer: A 2020 randomized controlled trial by Murphy et al., published in the _Journal of Clinical Sleep Medicine_, serves as a landmark study evaluating the nighttime and morning safety of sleep aids. The study specifically assessed the effects of lemborexant on middle-of-the-night awakening, auditory awakening thresholds, postural stability, and cognitive function upon morning awakening in healthy older adults. ![1](https://www.rapamycin.news/uploads/default/original/3X/a/e/aec4e0803dfb518c6c96eea427851eff50efe251.jpeg) The results demonstrated that, compared to placebo, the lemborexant 5 mg and 10 mg groups showed no changes in auditory awakening thresholds. Their morning body sway, as well as their performance on attention and memory tests, showed no statistically significant differences from the placebo group. In contrast, zolpidem extended-release (the active comparator) not only significantly increased body sway but also markedly impaired cognitive performance and awakenability. This study directly confirmed that, for the vast majority of individuals—even when awakened in the middle of the night—lemborexant causes virtually no suppression of consciousness or motor function, nor does it noticeably affect morning alertness. Whether a sleep medication impairs driving ability after administration is another primary concern for the general public. In 2019, Vermeeren et al. published a randomized, double-blind, placebo-controlled on-the-road driving study in _Sleep_, conducted on healthy adult and elderly volunteers. ![2](https://www.rapamycin.news/uploads/default/original/3X/1/3/13dc8772f87c8631c14862e31c35e806e0f01ec1.jpeg) The findings showed that approximately 9 hours after bedtime administration of lemborexant 5 mg or 10 mg, subjects’ lane position deviations and driving error rates during a highway driving test were completely identical to those of the placebo group, showing zero impairment in driving performance. By contrast, nearly 50% of subjects in the zopiclone positive control group experienced significant driving impairment, with a substantial increase in lane drift. Logically, if a drug remains in the body longer, it should cause greater grogginess the next day. Why do clinical studies consistently prove that lemborexant causes almost no residual next-day somnolence and doesn’t even impair morning driving? The answer lies in a common misconception regarding the concept of “half-life.” Many believe that a long half-life means the drug remains continuously active in the body, leading to morning grogginess. In reality, lemborexant possesses a unique pharmacokinetic profile: **fast receptor association and fast dissociation**. An _in vitro_ receptor study by Beuckmann et al. published in the _Journal of Pharmacology and Experimental Therapeutics_ in 2017 first demonstrated that lemborexant binds to and dissociates from orexin receptors significantly faster than other contemporary dual orexin receptor antagonists (DORAs). ![3](https://www.rapamycin.news/uploads/default/original/3X/0/4/04bd85a5c7753d46a99a42d6c112901bdce7020b.jpeg) Consequently, after nighttime administration, lemborexant rapidly binds to orexin receptors, blocking wakefulness signals to promote fast sleep onset and sleep maintenance throughout the night. By the next morning, it rapidly dissociates from the receptors. Even if trace amounts of the drug remain in the bloodstream, they no longer exert a significant sleep-promoting effect, naturally avoiding morning somnolence. This mechanism is further consistent with the Phase III clinical trial results of lemborexant in China. ---
**Author:** ![LukeMV](https://www.rapamycin.news/letter_avatar_proxy/v4/letter/l/7cd45c/32.png) [@LukeMV](https://www.rapamycin.news/u/LukeMV)\ **Post date:** [November 1, 2026, 12:19pm UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548/66 "2026-11-01T12:19:43Z")
I gave it a few days. Sometimes I would STILL be groggy until 6pm the next day. This drug is absolutely horrible for me. I also tried Hydroxyzine after (not an orexin). Almost the same issue. I seem to be particularly sensitive to next day grogginess There is one orexin drug called Daridorexant that is an 8 hour half life. I would give that one a shot but it’s not easy to get. ---
**Author:** ![touringsedan](https://www.rapamycin.news/letter_avatar_proxy/v4/letter/t/73ab20/32.png) [@touringsedan](https://www.rapamycin.news/u/touringsedan)\ **Post date:** [November 1, 2026, 1:46pm UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548/67 "2026-11-01T13:46:34Z")
Amazing for sleep for me… hitting 2.5 hrs of REM and Deep easily with it and staying asleep longer and can fall back asleep fast (even though it feels like it doesn’t in my mind). However, for me, after a week of 10mg daily, it compounded and gave me three days (while off the drug) of extraordinary exhaustion, it felt like I hadn’t slept in days. Going to give Quviviq a try and see if that helps. |Drug Name|Half-Life| |Daridorexant (Quviviq)|8 hours| |Suvorexant (Belsomra)|12 hours| |Lemborexant (Dayvigo)|17 to 55 hours| ---
**Author:** ![Davin8r](https://www.rapamycin.news/user_avatar/www.rapamycin.news/davin8r/32/30524_2.png) [@Davin8r](https://www.rapamycin.news/u/Davin8r)\ **Post date:** [November 1, 2026, 2:45pm UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548/68 "2026-11-01T14:45:27Z")
The only explanation i can think of would be that there is subjective morning grogginess that isn’t captured by the testing used in the studies. Remember these studies are run by the drug manufacturers, so they could be choosing tests that favor the drug. Quvuviq (daridi) caused me to wake up too early in the morning (consistent w/short half-life), so after a year or so I switched to Belsomra (intermediate half-life), which works pretty well for me w/minimal sedation when I wake up, so I don’t have a need to try Dayvigo. ---
**Author:** ![Rika\_Qu](https://www.rapamycin.news/user_avatar/www.rapamycin.news/rika_qu/32/36912_2.png) [@Rika\_Qu](https://www.rapamycin.news/u/Rika_Qu)\ **Post date:** [November 6, 2026, 12:42am UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548/69 "2026-11-06T00:42:07Z")
> [@Davin8r](#): > > Dayvigo N=1 datapoint here. I am on low-dose 1.25 or 2.5mg Dayvigo for 3 months, I am able to function properly and feel more energetic and motivated. However, I lose some weight (5 pounds), suspecting orexin affects metabolism pathways. ---
**Author:** ![Phillipe](https://www.rapamycin.news/letter_avatar_proxy/v4/letter/p/22d042/32.png) [@Phillipe](https://www.rapamycin.news/u/Phillipe)\ **Post date:** [November 6, 2026, 9:44pm UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548/70 "2026-11-06T21:44:52Z")
Below is a GoodRx discount coupon terms for Dayvigo found today- 30 tabs/10mg-$135. I can get a Rx for it but the regular price is outrageous. However, I can’t get it filled at the discounted price because of these limitations. I’m over 65, on Medicare but willing to pay cash, pharmacy will not honor. Seems ridiculous. “This coupon is not available to patients enrolled in federal or state healthcare programs, including Medicare, Medicaid, Medigap, VA, DoD, or Tricare. This coupon is not available to patients 65 years of age or older” ---
**Author:** ![DavidCary](https://www.rapamycin.news/letter_avatar_proxy/v4/letter/d/49beb7/32.png) [@DavidCary](https://www.rapamycin.news/u/DavidCary)\ **Post date:** [November 8, 2026, 10:26am UTC](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548/71 "2026-11-08T10:26:32Z")
These coupon programs are maddening. I had one for Dayvigo about 6 months ago that was like $35. I was expecting the $135 goodrx price so I was very excited. Went to fill the next month and it was $135. They said the program “ran out of money” to give me more of a discount and it wasn’t a 1 month teaser. What a crock of poo. The price in other countries (like India) is $20 a month. The maker is a small Japanese company so you can’t even blame on “big pharma”. They are so small that when you call them you get some generic pharm customer service company that basically reads from a script - the person didn’t even know what the drug does. Anyway, they gave me a teaser price like your corner drug dealer would give you to get you hooked. I could go on and on about pharma pricing. I don’t understand how the US public has been so convinced that public health care is so bad but paying $500 a month for a med that other countries pay $20 for makes any sense at all. Auvelity is so disgusting I like to share the details. It is for dementia with agitation. It retails at $1500 a month. It is a combo of dextromethorphan and bupropion. 2 drugs that are pennies. Goodrx is $1200. The audacity is practically criminal. Every see the ads for TED (thyroid eye disease)? The cost is $200k for 6 months treatment. At least it is a novel drug. [Previous page](https://www.rapamycin.news/t/is-dayvigo-lemborexant-a-safe-sleep-pill/21548.md?page=3)